Benign Prostate Hyperplasia
Conditions
Interventions
trial group:Mirabegron
control group:Nil
Sponsors
The First Affiliated Hospital of Xian Jiaotong University
Eligibility
Sex/Gender
Male
Age
50 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Subjects over 50 years old who are scheduled to undergo surgery for benign prostatic hyperplasia; 2. Progressive dysuria and BPH confirmed by B-ultrasound; 3. Benign prostatic hyperplasia operation indications: such as repeated urinary retention, hematuria, bladder stones, recurrent infection, symptoms seriously affectthe quality of life, drug treatment is invalid or unwilling to take medicine; 4. Good compliance, the subjects themselves or their family members can complete the app operation; 5. Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Serious cardiovascular and cerebrovascular diseases, important organ dysfunction and other contraindications for BPH surgery; 2. Neurogenic bladder and urethra dysfunction, urethral stricture and other concomitant diseases that affect the surgical effect; 3. Subjects suspected of prostate cancer by PSA and imaging examination; 4. Subjects allergic to Mirabella and its ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OABSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| IPSS;QoL;VAS; | — |
Countries
China
Contacts
Public ContactDalin He
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed